The DOI matches its Crossref record; 176 of the 177 references it cites were found in a registry or an index; 17 of the 166 sources its claims cite were checked for support.
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
Open accessAbstract
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes have been debated extensively. The concept that a feedback loop governs the interaction of the insulin-sensitive tissues and the beta cell as well as the elucidation of the hyperbolic relationship between insulin sensitivity and insulin secretion explains why insulin-resistant subjects exhibit markedly increased insulin responses while those who are insulin-sensitive have low responses. Consideration of this hyperbolic relationship has helped identify the critical role of beta-cell dysfunction in the development of Type 2 diabetes and the demonstration of reduced beta-cell function in high risk subjects. Furthermore, assessments in a number of ethnic groups emphasise that beta-cell function is a major determinant of oral glucose tolerance in subjects with normal and reduced glucose tolerance and that in all populations the progression from normal to impaired glucose tolerance and subsequently to Type 2 diabetes is associated with declining insulin sensitivity and beta-cell function. The genetic and molecular basis for these reductions in insulin sensitivity and beta-cell function are not fully understood but it does seem that body-fat distribution and especially intra-abdominal fat are major determinants of insulin resistance while reductions in beta-cell mass contribute to beta-cell dysfunction. Based on our greater understanding of the relative roles of insulin resistance and beta-cell dysfunction in Type 2 diabetes, we can anticipate advances in the identification of genes contributing to the development of the disease as well as approaches to the treatment and prevention of Type 2 diabetes.
Overview
CoChat Summary
TL;DR
This review argues that insulin resistance and beta-cell dysfunction are both present early in the natural history of Type 2 diabetes, and that beta-cell function must be interpreted relative to insulin sensitivity through the hyperbolic/disposition-index relationship. It concludes that progressive beta-cell failure is a major determinant of worsening glucose tolerance, while intra-abdominal fat is a key determinant of insulin resistance.
Key findings
- The relationship between insulin sensitivity and insulin secretion is non-linear and best described as hyperbolic; the product of insulin sensitivity and insulin response (disposition index) is constant for a given degree of glucose tolerance. This was shown in 93 healthy subjects younger than 45 years and confirmed in Danish and Pima Indian cohorts.
- In 531 first-degree relatives of Type 2 diabetic subjects from four ethnic groups, beta-cell function adjusted for insulin sensitivity accounted for 45% of the variance in glucose disposal, compared with 8% for insulin sensitivity alone and 29% for the early insulin response alone. Among subjects with normal glucose tolerance, those with poorer glucose disposal had reduced beta-cell function but no difference in insulin sensitivity.
- In Pima Indians followed for an average of 5 years, those progressing to diabetes had a 78% decline in insulin secretion while insulin sensitivity decreased by only 14%; non-progressors had an 11% decrease in insulin sensitivity accompanied by a 30% increase in insulin secretion.
- Intra-abdominal fat was the strongest correlate of insulin sensitivity, explaining 47% of its variance in 174 subjects. Prevention trials cited include DPP lifestyle intervention reducing diabetes development by 58% and metformin by 31%, STOP-NIDDM acarbose by 25%, and TRIPOD troglitazone by 55%; in UKPDS, after 9 years only 25% of the intensive-treatment arm achieved HbA1c below 7% with monotherapy.
Methods
- Narrative review based on English-language literature published during 1990–2001 and seminal prior contributions, integrated with PubMed searches for “insulin resistance, diabetes and humans” and “insulin secretion, diabetes and humans.”
- Synthesizes cross-sectional and longitudinal human studies, including a 174-subject cohort (73 men/101 women, age 30–75 years), 531 first-degree relatives from four ethnic groups, and Pima Indian follow-up data; no new primary data are reported.
Limitations
- Stated: the genetic and molecular basis for reductions in insulin sensitivity and beta-cell function are not fully understood; the mechanism(s) by which body-fat distribution influences insulin sensitivity are unclear; whether beta-cell regulation is governed by a central neural process or a humoral signal is unknown; and mechanisms by which lifestyle or metformin reduced diabetes development in prevention studies had not yet been reported.
- Stated: at the time of writing, no known pharmacological intervention was capable of preventing the progressive decline in beta-cell function in Type 2 diabetic patients.
- Evident: as a narrative review, it does not use a systematic search or meta-analysis and relies on heterogeneous observational and intervention studies, limiting causal inference.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 64 Not checked · 42 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Our finding of a hyperbolic relationship between insulin sensitivity and insulin secretion in healthy subjects has been confirmed in large cohorts of Danish [94] and Pima Indian subjects [95].”
What the sources say
- Disputedcites [94] Clausen JO, Borch-Johnsen K, Ibsen H et al. (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98:1195–1209 sourceExperimental — accuracy not yet measured
Our copy of Clausen et al. (1996) does report a large, population-based Danish sample (380 young healthy Caucasians, Results/Table II), but on the decisive point it says the opposite of confirmation: in the discussion of the insulin sensitivity index vs. insulin secretion it states 'we were not able to demonstrate from a statistical perspective that the hyperbola was the best analytic function to account for the data in our population,' noting a straight line with negative slope or a parabola fits equally or better (Figure 5 section). The Results add that 'a standard linear model gives a significantly better description than the other models' and that adding a parabolic term improved the fit significantly, and that the coefficient of variation of the product (0.60) was not lower than that of the individual variables (0.61 and 0.70), i.e. the disposition index was not a constant. The authors explain that because the cohort contained only young, relatively lean subjects the 'rising limb' of the hyperbola was never observed and they lacked 'a broad enough population base ... to have power to determine the best function.' Thus citing this paper as confirming the hyperbolic relationship in a large Danish cohort is contradicted by the paper itself. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Supportedcites [95] Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794 source
In 'Relation between changes in insulin secretion and insulin action' our copy states that a hyperbolic relationship between early insulin secretion and insulin action is well known in individuals with normal glucose tolerance and that 'Figure 2 depicts this hyperbolic relationship between AIR and M-low in 277 Pima Indians with NGT'; the Figure 2 legend likewise gives the regression between AIR and M-low derived from a reference population of 277 Pima Indians with NGT. This supplies the Pima Indian half of the claim (large cohort, healthy/NGT subjects); the Danish cohort is carried by the separate citation [94] and is not part of what is attributed to this source. The paper's disposition-index results (nonprogressors' compensatory rise in AIR with falling M-low) further corroborate the hyperbolic compensation relationship. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“it has become apparent that the relationship between BMI and insulin sensitivity is non-linear, rather than linear as had been traditionally thought.”
What the sources say
- Not checked yetcites [54] Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and B-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672 source
- Partly supportedcites [38] Cnop M, Landchild MJ, Vidal J et al. (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005–1015 sourceExperimental — accuracy not yet measured
The Methods say the relationships between insulin sensitivity and untransformed measures of body fat appeared nonlinear, and the Results report an inverse correlation with BMI. However, the paper specifically tests and confirms nonlinearity for intra-abdominal fat, not BMI, and does not establish that a linear BMI relationship was traditionally assumed. (LLM, conf=0.82)
plainstates an associationn = 174- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“These findings derived from cross-sectional data are supported by a longitudinal study in Pima Indians that has also shown the importance of accounting for the hyperbolic relationship between insulin sensitivity and insulin secretion and demonstrated the presence of impaired beta-cell function in those destined to progress to Type 2 diabetes [95].”
What the sources say
- Supportedcites [95] Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794 source
In “Relation between changes in insulin secretion and insulin action” (page not provided), the paper reports that insulin secretion was already too low relative to insulin resistance in Pima Indian participants who later developed diabetes, even while they had normal glucose tolerance. It uses the hyperbolic relationship between insulin secretion and action to make that assessment. (LLM, conf=0.93)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As postulated previously [93], we found that the relationship between insulin sensitivity and insulin secretion is non-linear and best described by a hyperbolic function.”
What the sources say
- Partly supportedcites [93] Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467 sourceExperimental — accuracy not yet measured
Figure 5 (Discussion, p. 9) plots second-phase pancreatic responsiveness against insulin sensitivity and shows a constant-product line, φ2·S = 75, which is hyperbolic. The passage uses that line to distinguish glucose-tolerance regions; it does not say the observed relationship between insulin sensitivity and secretion was best described by a hyperbolic function. (LLM, conf=0.83)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“obesity and its associated insulin resistance are associated with basal and stimulated hyperinsulinaemia [10, 68, 91, 92].”
What the sources say
- Not checked yetcites [10] Beard JC, Ward WK, Halter JB, Wallum BJ, Porte D Jr (1987) Relationship of islet function to insulin action in human obesity. J Clin Endocrinol Metab 65:59–64 source
- Partly supportedcites [68] Perley MJ, Kipnis DM (1967) Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest 46:1954–1962 sourceExperimental — accuracy not yet measured
The Results report excessive glucose-stimulated plasma insulin responses in obese subjects, and the discussion describes significant insulin antagonism associated with obesity. The passages do not establish basal hyperinsulinaemia; a search for basal and fasting insulin found no group comparison of basal levels. Page numbers are unavailable in our copy. (LLM, conf=0.87)
- Not checked yetcites [91] Karam JH, Grodsky GM, Forsham PH (1963) Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12:197–204 source
- Not checked yetcites [92] Bagdade JD, Porte D Jr, Brunzell JD, Bierman EL (1974) Basal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity. J Lab Clin Med 83:563–569
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
66 more claims · 7 with their cited sources checked
Create a free account to see all 121 claims and to verify the 149 references still open.
- It may state two separate claims as one. 47
- Probably not a substantial claim. 2
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such a decrease in second phase insulin secretion would take more than a decade to emerge in most T2DM patients presenting in middle or later life [21][22] .”
From Type 2 diabetes in adolescents and young adults (2018) · cites this paper as [22]
Experimental — accuracy not yet measuredIn the citing paper
“β-cell function however cannot be characterised solely on the basis of insulin secretion without the consideration of the underlying insulin resistance.”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [47]
In the citing paper
“According to this concept, the relation between insulin secretion and insulin sensitivity is hyperbolic; the ratio of incremental insulin over incremental glucose divided by insulin resistance is described by a constant, the disposition index.39,47”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Insulin resistance and beta-cell dysfunction: where are we now and what does the future hold? · p. 12
“Two more large prevention studies examining the effects of the insulin sensitizer rosiglitazone [163] and the beta-cell secretagogue nateglinide [164]”
§ References · p. 17
“163. Yusuf S, Gerstein H, Hoogwerf B et al. (2001) Ramipril and the development of diabetes.”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“This Swedish study provided the basis for the design of the Da Qing study in China [158], the Finnish Diabetes Prevention Study [159] and the DPP carried out in the United States [16].”
MethodReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Research works printed but not linked: 2
- Kahn SE (1996) Regulation of B-cell function in vivo: from health to disease. Diabetes Rev 4:372–389
- Landchild MJ, Knowles NG, Yao Q et al. (2000) Increased β-cell secretory demand is not the simple explanation for inefficient proinsulin processing and islet amyloid formation in type 2 diabetes. J Investig Med 48:21A (Abstract)
Cited by
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Self-citationCosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Metadata
- Authors
- Kahn, S. E.
- Affiliations
- University of Washington (US)
- Corresponding author
- Kahn, S. E.
- ORCID
- Kahn, S. E.
- Venue
- Diabetologia
- Published
- 2003-01
- Volume
- 46
- Issue
- 1
- Pages
- 3-19
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2004014076
- Cited by
- 2,166
- References
- 177
- Citations by year
- 2026: 45 · 2025: 54 · 2024: 88 · 2023: 85 · 2022: 99 · 2021: 105 · 2020: 110 · 2019: 95 · 2018: 109 · 2017: 105 · 2016: 90 · 2015: 110 · 2014: 134 · 2013: 120 · 2012: 95
- FWCI
- 13.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (DK-17047)
- National Institutes of Health (RR-37)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050703, K24DK002654, DK50703, DK 02654, DK-17047, P30DK017047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, insulin resistance, beta-cell dysfunction, insulin sensitivity, insulin secretion, hyperbolic relationship, beta-cell mass, intra-abdominal fat, body fat distribution, oral glucose tolerance, impaired glucose tolerance, genetic susceptibility, disease prevention
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Islets of Langerhans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. https://app.cochat.ai/papers/10.1007/s00125-002-1009-0
- The paper
- Kahn, S. E. (2003). The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. https://doi.org/10.1007/s00125-002-1009-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.